Biotech · Private company · Marlborough, MA, US
Assayquant Technologies, Inc.
Track this companyFree. Adds Assayquant Technologies, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Selective Sensor Peptides for High-throughput, Kinetic Biomarker Assays of Kinase Activity in Neurodegeneration and Related DisordersFiscal year 2026 · $1.3MNIH RePORTER 1R44AG102290-01 · fetched Nov 12, 2026
- Activity-based Sensor Peptides for Direct, High-throughput, and Kinetic Quantitation of Oncogenic Protein Kinases in Unfractionated Cell and Tissue SamplesFiscal year 2025 · $906.9KNIH RePORTER 5R44CA295425-02 · fetched Nov 12, 2026
- Activity-based Sensor Peptides for Direct, High-throughput, and Kinetic Quantitation of Oncogenic Protein Kinases in Unfractionated Cell and Tissue SamplesFiscal year 2024 · $1.1MNIH RePORTER 1R44CA295425-01 · fetched Nov 12, 2026